These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New perspectives in vaccine development: mucosal immunity to infections. McGhee JR; Kiyono H Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356 [TBL] [Abstract][Full Text] [Related]
8. Vaccines for mucosal immunity to combat emerging infectious diseases. van Ginkel FW; Nguyen HH; McGhee JR Emerg Infect Dis; 2000; 6(2):123-32. PubMed ID: 10756145 [TBL] [Abstract][Full Text] [Related]
9. Delivery strategies to enhance oral vaccination against enteric infections. Davitt CJ; Lavelle EC Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337 [TBL] [Abstract][Full Text] [Related]
10. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Lawson LB; Norton EB; Clements JD Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452 [TBL] [Abstract][Full Text] [Related]
11. Induction of mucosal immunity through systemic immunization: Phantom or reality? Su F; Patel GB; Hu S; Chen W Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023 [TBL] [Abstract][Full Text] [Related]
12. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. McGhee JR; Mestecky J Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002 [TBL] [Abstract][Full Text] [Related]
13. Mucosal delivery of vaccine antigens and its advantages in pediatrics. De Magistris MT Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335 [TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles. Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573 [TBL] [Abstract][Full Text] [Related]
15. Induction of protective immune responses at respiratory mucosal sites. Park SC; Wiest MJ; Yan V; Wong PT; Schotsaert M Hum Vaccin Immunother; 2024 Dec; 20(1):2368288. PubMed ID: 38953250 [TBL] [Abstract][Full Text] [Related]
16. Modes of Action for Mucosal Vaccine Adjuvants. Aoshi T Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755 [TBL] [Abstract][Full Text] [Related]
17. [Mucosal immunity and vaccine development]. Anjuère F; Czerkinsky C Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226 [TBL] [Abstract][Full Text] [Related]
18. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]
19. Rational application of nanoadjuvant for mucosal vaccine delivery system. Dewangan HK J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695 [TBL] [Abstract][Full Text] [Related]